LYRA
Price
$4.16
Change
+$0.15 (+3.74%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
6.6M
Intraday BUY SELL Signals
TBPH
Price
$18.89
Change
+$0.47 (+2.55%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
993.43M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LYRA vs TBPH

Header iconLYRA vs TBPH Comparison
Open Charts LYRA vs TBPHBanner chart's image
Lyra Therapeutics
Price$4.16
Change+$0.15 (+3.74%)
Volume$408
Capitalization6.6M
Theravance Biopharma
Price$18.89
Change+$0.47 (+2.55%)
Volume$8.92K
Capitalization993.43M
LYRA vs TBPH Comparison Chart in %
LYRA
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LYRA vs. TBPH commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a StrongBuy and TBPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (LYRA: $4.09 vs. TBPH: $18.43)
Brand notoriety: LYRA and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 134% vs. TBPH: 37%
Market capitalization -- LYRA: $6.6M vs. TBPH: $993.43M
LYRA [@Biotechnology] is valued at $6.6M. TBPH’s [@Biotechnology] market capitalization is $993.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 1 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • LYRA’s FA Score: 1 green, 4 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both LYRA and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 5 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • LYRA’s TA Score: 5 bullish, 2 bearish.
  • TBPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than TBPH.

Price Growth

LYRA (@Biotechnology) experienced а +42.19% price change this week, while TBPH (@Biotechnology) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($993M) has a higher market cap than LYRA($6.6M). TBPH YTD gains are higher at: 95.855 vs. LYRA (-60.320). TBPH has higher annual earnings (EBITDA): 46.1M vs. LYRA (-35.34M). TBPH has more cash in the bank: 339M vs. LYRA (29.8M). LYRA has less debt than TBPH: LYRA (32.5M) vs TBPH (46.5M). TBPH has higher revenues than LYRA: TBPH (77.2M) vs LYRA (770K).
LYRATBPHLYRA / TBPH
Capitalization6.6M993M1%
EBITDA-35.34M46.1M-77%
Gain YTD-60.32095.855-63%
P/E RatioN/A34.39-
Revenue770K77.2M1%
Total Cash29.8M339M9%
Total Debt32.5M46.5M70%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYRATBPH
RSI
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
67%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 6 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 6 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 27 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
89%
Bearish Trend 6 days ago
69%
Aroon
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 6 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBLG2.210.21
+10.50%
Oblong Inc
CBZ49.761.15
+2.37%
CBIZ
NWPX58.120.22
+0.38%
NWPX Infrastructure Inc
PNR105.150.09
+0.09%
Pentair plc
NOEM10.24N/A
N/A
CO2 Energy Transition Corp

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+9.79%
EYPT - LYRA
58%
Loosely correlated
-4.00%
VERA - LYRA
55%
Loosely correlated
+12.88%
KYMR - LYRA
51%
Loosely correlated
-3.80%
CLNN - LYRA
39%
Loosely correlated
-2.09%
TBPH - LYRA
37%
Loosely correlated
-6.02%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-6.02%
KYMR - TBPH
45%
Loosely correlated
-3.80%
VERA - TBPH
37%
Loosely correlated
+12.88%
VYGR - TBPH
37%
Loosely correlated
-4.89%
LYRA - TBPH
36%
Loosely correlated
+9.79%
AXON - TBPH
34%
Loosely correlated
+0.91%
More